CD19 and colorectal carcinoma: Furthermore, the expression of CD3G (T-cell marker), CD8A (CD8+ T-cell marker), CD19 (B-cell marker), and PD-L1 (an immunotherapy target of CRC) maintained the same trend as immune infiltration among these clusters (Figure S1A-D).